Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shreya Shrestha, M.D.

Concepts (61)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Platelet Aggregation Inhibitors1201727460.240 Why?
Brain Ischemia1201730310.210 Why?
Anticoagulants1201747950.190 Why?
Coronary Angiography3201945060.160 Why?
Endothelin-1120183010.140 Why?
Neprilysin120194780.130 Why?
Catheters120184260.130 Why?
Stroke1201797200.120 Why?
Tetrazoles120199090.110 Why?
Natriuretic Peptide, Brain1201917250.090 Why?
Chemistry, Pharmaceutical120102740.080 Why?
Administration, Oral1201740140.080 Why?
Drug Resistance, Microbial120108260.070 Why?
Acute Kidney Injury1201919230.070 Why?
Endothelium, Vascular1201844210.070 Why?
Contrast Media1201953110.060 Why?
Proteomics1201938360.060 Why?
Renal Insufficiency, Chronic1201822540.060 Why?
Microbial Sensitivity Tests1201019360.060 Why?
Artificial Intelligence1201925770.060 Why?
Cardiovascular Diseases22018155130.050 Why?
Risk Assessment22019240130.040 Why?
Bacteria1201021900.040 Why?
Pharmacological Phenomena12019110.040 Why?
Heart Failure12019117010.030 Why?
Biphenyl Compounds1201910070.030 Why?
Creatinine1201918970.030 Why?
Catheterization1201814280.030 Why?
Drug Monitoring120199610.030 Why?
Drug Combinations1201920480.030 Why?
Angiotensin Receptor Antagonists1201910390.030 Why?
Predictive Value of Tests22019153080.020 Why?
Anti-Bacterial Agents1201074050.020 Why?
Agar12010510.020 Why?
ROC Curve1201935820.020 Why?
Tetracycline120102160.020 Why?
Glomerular Filtration Rate1201821810.020 Why?
Soil120101160.020 Why?
Prognosis22018296720.020 Why?
Protein Isoforms1201016960.020 Why?
Drug Design1201010450.020 Why?
Drug Evaluation, Preclinical1201013310.020 Why?
Stroke Volume1201955200.020 Why?
Sex Factors12018105520.010 Why?
Humans620197610980.010 Why?
Prospective Studies22019544190.010 Why?
Proportional Hazards Models12018124670.010 Why?
Anti-Infective Agents120109830.010 Why?
Disease Progression12018135060.010 Why?
Prevalence12018157170.010 Why?
Male420193606750.010 Why?
Incidence12019213570.010 Why?
Female420193924580.010 Why?
Coronary Artery Disease1201965040.010 Why?
Escherichia coli1201042050.010 Why?
Cross-Sectional Studies12018260680.010 Why?
Follow-Up Studies12018391210.010 Why?
Aged220191692660.010 Why?
Middle Aged220192208350.010 Why?
Image Processing, Computer-Assisted1201090010.010 Why?
Risk Factors12018742190.010 Why?
Shrestha's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (61)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.